iRadimed Corporation Reports First Quarter 2026 Financial Results

iRadimed Corporation announced strong financial results for the first quarter of 2026, reporting a revenue of $22.0 million, up 13% from the previous year, with a net income of $5.8 million. The company launched its next-generation MRI-compatible IV infusion pump, boosting customer interest and orders. The company reaffirmed its full-year 2026 financial guidance and declared a quarterly cash dividend of $0.20 per share.